Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
11/2005
11/16/2005CN1227221C Ternary sulfonimine alkali salt and synthesis method thereof
11/15/2005US6965051 Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith
11/15/2005US6965048 Hydroxyalkylamide derivatives
11/10/2005WO2005105744A1 Histamine-3 receptor antagonists
11/10/2005WO2005105712A1 Sulfonamide derivatives
11/10/2005WO2005095326A3 2-amino- and 2-thio-substituted 1,3-diaminopropanes
11/10/2005WO2005064349A3 Detection cartridges, modules, systems and methods
11/10/2005US20050250959 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/10/2005CA2564258A1 Histamine-3 receptor antagonists
11/09/2005EP1593671A1 DPP-IV inhibitors
11/09/2005EP1592656A2 Medicinal compounds
11/09/2005EP1212296B1 Phosphate mimics and methods of treatment using phosphatase inhibitors
11/09/2005EP1144371B1 Benzenesulphonamide derivatives and their use as mek inhibitors
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005EP0975353B1 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
11/09/2005EP0844874B1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF ALPHA v BETA 5 MEDIATED ANGIOGENESIS
11/09/2005CN1226284C N-sulphonyl and N-sulphinyl phenylglycinamide
11/08/2005US6963011 Central nervous system disorders; psychological disorders
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005US6962929 Drugs such as 4-(N,N-Dimethylamino)-1-pentafluorophenyl-sulfonamidobenzene and/or prodrugs, used as anticarcinogenic agents, microbiocides or bactericides; tubulin inhibitors
11/03/2005WO2005102989A1 Non-nucleoside reverse transcriptase inhibitors
11/03/2005US20050245615 Treating proliferative cutaneous disease using a polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; e.g. lupus; use with other biosynthesis enzyme inhibitors
11/03/2005US20050245602 Selective estrogen receptor modulators
11/03/2005US20050245573 N-substituted benzene sulfonamides
11/03/2005US20050245543 Histamine-3 receptor antagonists
11/03/2005US20050245535 Sulfonyl amide inhibitors of calcium channel function
11/03/2005US20050244812 Kits and methods for detection of apoptotic cells
11/03/2005CA2563180A1 Non-nucleoside reverse transcriptase inhibitors
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590327A1 Ccr8 inhibitors
11/02/2005EP1590314A2 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
11/02/2005EP1242363B1 Cd45 inhibitors
11/02/2005EP1159261B1 Antizyme modulators and their use
11/02/2005EP0973739B1 N-arylsulfonamide- and pyrrolidinecarboxylic acid intermediates, and their use for the preparation of herbicidal 1,3-dioxo-1h-pyrrolo[1,2-c]imidazole derivatives
11/02/2005CN1692098A Sulfonamide derivatives, insecticides for agricultural and horticultural use, and usage thereof
11/02/2005CN1225464C Extraction technology of Hanbaicalein, medicinal composition and preparation technology of medicine
11/01/2005US6960686 Preparation and purification of antiviral disulfonic acid disodium salt
11/01/2005US6960664 Aza hydroxylated ethyl amine compounds
11/01/2005US6960574 Antagonists of RF-amide neuropeptides
11/01/2005CA2177586C 4-benzoylisoxazoles and their use as herbicides
10/2005
10/27/2005WO2005100298A1 Cetp inhibitors
10/27/2005WO2005061433A3 Aminoalcohol derivatives
10/27/2005WO2004113275A3 Methods and compositions for treating amyloid-related diseases
10/27/2005US20050240052 Process for producing fluorine-containing alkylsulfonylaminoethyl a-substitued acrylate
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050239887 Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes
10/27/2005US20050239881 viricides; polymerase inhibitors; therapy for genetic engineered virus
10/27/2005US20050239802 E.g., 6-{2-[5-Chloro-2-(2,4-difluorobenzyloxy)- phenyl]cyclopent-1-enyl}-pyridine-2-carboxylic acid, used to treat prostaglandin mediated diseases that include inflammatory, neuropathic or visceral pain
10/27/2005CA2562082A1 Cetp inhibitors for the treatment and prevention of atherosclerosis
10/26/2005EP1589000A2 (R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
10/26/2005EP1587535A2 Title of the invention n-cyclohexylaminocarbonyl benzenesulfonamide derivatives
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005CN1687025A New technique for synthesizing aglycon of soybean
10/26/2005CN1224598C Naphthalene derivatives
10/25/2005US6958416 Valproyltaurinamide derivatives as anticonvulsant amd CNS active agents
10/25/2005US6958331 sulfonyl amine derivatives such as {2-(2,2-diphenyl-ethylamino)-5-[4-(4-isopropyl-piperazine-1-carbonyl)-piperidine-1-sulfonyl]-phenyl}-morpholin-4-yl-methanone; pain, inflammation, septic shock
10/25/2005CA2304974C 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/20/2005WO2005097788A2 Sulfonamides and uses thereof
10/20/2005WO2005097773A1 1,1’-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors
10/20/2005WO2005097738A1 Novel sulfonamide derivative
10/20/2005WO2005061450A3 Hiv protease inhibiting sulfonamides
10/20/2005US20050234253 bidentate organophosphorous ferrocenyl ligands that create a highly asymmetric coordination sphere
10/20/2005US20050234125 Alpha-sulfonylamino-acetonitriles
10/20/2005US20050234109 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005CA2561801A1 Sulfonamides and uses thereof
10/20/2005CA2560648A1 1,1'-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors
10/19/2005EP1586558A2 Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
10/19/2005EP1586557A1 4-nitro-2- (4 -methoxy)-phenoxy -methanesulfonanilide derivates and their pharmaceutical use
10/19/2005EP1586556A2 Compounds to treat Alzheimer's disease
10/19/2005EP1585511A2 Asthma and allergic inflammation modulators
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1194414B1 Process for preparing 2-amino-4-(4-fluorphenyl)-6-alkylpyrimidine-5-carboxylate
10/19/2005EP1144373B1 Serine protease inhibitors
10/19/2005CN1684944A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005CA2294171C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
10/18/2005CA2137441C Amino-substituted benzenesulfonylureas and -thioureas, processes for their preparation, and their use as pharmaceuticals
10/18/2005CA2125730C Novel sulfonylamino pyrimidines
10/18/2005CA2117511C N-cyanoaryl-nitrogen heterocycles
10/13/2005WO2005095362A1 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd
10/13/2005WO2005095343A1 Dpp-iv inhibitors
10/13/2005WO2005095334A1 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005095326A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/13/2005WO2005094810A2 Novel pharmaceutical compositions
10/13/2005WO2004113277A3 Methods and compositions for treating amyloid-related diseases
10/13/2005US20050228017 Novel anticancer compounds
10/13/2005US20050228015 Substituted heteroaryl- and phenylsulfamoyl compounds
10/13/2005US20050227994 Decomposition inhibitor for extracellular matrix of cartilage
10/13/2005US20050227990 Aminoalkoxy-functional chalcones
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227982 Antileishmanial dinitroaniline sulfanomides with activity against parasite tubulin
10/13/2005US20050227973 Human adam-10 inhibitors
10/13/2005DE10392134T5 Azaphenylalaninderivate Azaphenylalaninderivate
10/13/2005CA2562700A1 Novel pharmaceutical compositions
10/13/2005CA2562114A1 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/13/2005CA2560773A1 2-amino- and 2-thio-substituted 1,3-diaminopropanes
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 177